Back to Results
First PageMeta Content
Collagen disease / Osteogenesis imperfecta / Collagen / type I / alpha 1 / Collagen / Dentinogenesis imperfecta / Teriparatide / COL1A2 / Osteoporosis / Hypophosphatasia / Anatomy / Medicine / Health


Document Date: 2013-12-31 08:49:41

Open Document

File Size: 244,25 KB

Share Result on Facebook

City

Edmonton / Baltimore / /

Company

Sanofi Aventis / Procter & Gamble Pharmaceuticals Inc. / Novartis Pharmaceuticals Corp. / Wyeth / Eli Lilly & Co. / /

Country

Iraq / /

Currency

USD / /

Facility

University of Washington / Baylor College of Medicine / Kennedy Krieger Institute / University of Alberta / /

MedicalCondition

hypophosphatasia / dentinogenesis imperfecta / restrictive pulmonary disease / disease / tissue disorder / L Detecting Osteogenesis Imperfecta O / heritable and systemic disease / postmenopausal osteoporosis / Pulmonary function studies / disorder / Osteogenesis imperfecta / Scoliosis / injuries / disorders / /

Organization

Baylor College of Medicine / Houston / Food and Drug Administration / Kennedy Krieger Institute / Bone Center / University of Washington / Seattle / University of Alberta / Army / /

Position

coordinator / director of the Osteogenesis Imperfecta Program / physician / pediatrician / international leader / /

Product

Proven / Forteo / vitamin D / dimetapp / /

ProvinceOrState

Alberta / /

Technology

x-ray / ultrasound / transplantation / gene analysis / /

URL

www.bcm.edu / www.kennedykrieger.org / www.oif.org / www.washington.edu / /

SocialTag